80 related articles for article (PubMed ID: 21057934)
1. Immunologic detection of benzo(a)pyrene-DNA adducts.
Santella RM; Zhang YJ
Methods Mol Biol; 2011; 682():271-8. PubMed ID: 21057934
[TBL] [Abstract][Full Text] [Related]
2. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers.
Hsu TM; Zhang YJ; Santella RM
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):193-9. PubMed ID: 9138663
[TBL] [Abstract][Full Text] [Related]
3. Immunologic methods for the detection of carcinogen adducts in humans.
Santella RM; Yang XY; Hsieh LL; Young TL
Prog Clin Biol Res; 1990; 340C():247-57. PubMed ID: 2199982
[TBL] [Abstract][Full Text] [Related]
4. The effect of humoral immunity against adducted benzo[a]pyrene on DNA damage elicited by acute carcinogen exposure in Swiss mice.
Galati R; Crebelli R; Zijno A; Conti L; Falasca G; Verdina A
In Vivo; 2000; 14(6):747-51. PubMed ID: 11204493
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-modified DNA and specific humoral immunity toward carcinogen-DNA adducts. A review.
Verdina A
Ann Ist Super Sanita; 2006; 42(2):189-94. PubMed ID: 17033140
[TBL] [Abstract][Full Text] [Related]
6. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
[TBL] [Abstract][Full Text] [Related]
7. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers.
Zhang YJ; Hsu TM; Santella RM
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):133-8. PubMed ID: 7537994
[TBL] [Abstract][Full Text] [Related]
8. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
9. Development of a monoclonal antibody recognizing benzo[c]phenanthrenediol epoxide-DNA adducts: application to immunohistochemical detection of DNA damage.
Zhang YJ; Geacintov NE; Santella RM
Chem Res Toxicol; 1997 Sep; 10(9):948-52. PubMed ID: 9305575
[TBL] [Abstract][Full Text] [Related]
10. [Immunological detection of carcinogen-DNA adducts].
Nakagawa K; Ishikawa T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):451-8. PubMed ID: 2495772
[TBL] [Abstract][Full Text] [Related]
11. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
Li D; Wang M; Dhingra K; Hittelman WN
Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
[TBL] [Abstract][Full Text] [Related]
12. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
Tierney B; Benson A; Garner RC
J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
[TBL] [Abstract][Full Text] [Related]
14. Detection of benzo[a]pyrene-DNA adducts from leukocytes from heavy smokers.
Arnould JP; Hermant A; Levi-Valensi P; Belegaud J
Pathol Biol (Paris); 1998 Dec; 46(10):787-90. PubMed ID: 9922995
[TBL] [Abstract][Full Text] [Related]
15. Monitoring human exposure to carcinogens by DNA adduct measurement.
Santella RM
Cell Biol Toxicol; 1988 Dec; 4(4):511-6. PubMed ID: 3228719
[TBL] [Abstract][Full Text] [Related]
16. Production of a high-affinity monoclonal antibody specific for 7-(benzo[alpha]pyren-6-yl) guanine and its application in a competitive enzyme-linked immunosorbent assay.
Casale GP; Rogan EG; Stack D; Devanesan P; Cavalieri EL
Chem Res Toxicol; 1996 Sep; 9(6):1037-43. PubMed ID: 8870993
[TBL] [Abstract][Full Text] [Related]
17. Immunological methods for detection of carcinogen-DNA damage in humans.
Santella RM
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):733-9. PubMed ID: 10498391
[TBL] [Abstract][Full Text] [Related]
18. Detection of benzo[a]pyrene-DNA adducts in cultured cells treated with benzo[a]pyrene diol-epoxide by quantitative immunofluorescence microscopy and 32P-postlabelling; immunofluorescence analysis of benzo[a]pyrene-DNA adducts in bronchial cells from smoking individuals.
Baan RA; van den Berg PT; Steenwinkel MJ; van der Wulp CJ
IARC Sci Publ; 1988; (89):146-54. PubMed ID: 3143666
[TBL] [Abstract][Full Text] [Related]
19. Determination of carcinogen-DNA adducts by immunoassay.
Poirier MC; Liou SH; Reed E; Strickland PT; Tockman MS
J UOEH; 1989 Mar; 11 Suppl():353-67. PubMed ID: 2664949
[No Abstract] [Full Text] [Related]
20. Synchronous fluorescence spectrophotometry of benzo[a]pyrene diol epoxide-DNA adducts: a tool for detection of in-vitro and in-vivo DNA damage by exposure to benzo[a]pyrene.
Vähäkangas K; Pelkonen O; Harris CC
IARC Sci Publ; 1988; (89):208-12. PubMed ID: 3143671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]